Home >   Late Phase >  Health Economics & Outcomes Research

Health Economics & Outcomes Research


Dedicated team of experience statisticians and medical writers
Helping clients improve drug development decisions

Conducting pharmacoeconomic research is an important component for the biopharmaceutical industry aiming to make decisions about drug development, pricing, marketing and evaluations of health outcomes. SGS helps clients design, conduct and analyze pharmacoeconomic and post-marketing studies, offering a flexible approach thanks to a dedicated team of statisticians and medical writers with extensive experience in these fields.

Services:

  • Sample size calculation
  • Development of a specific statistical analysis plan on request
  • Post-marketing survey analysis
  • Pharmacoeconomic trial design and analysis
  • Burden of illness assessment
  • Disease management
  • Economic evaluations
  • Decision making analysis using Markov-Chain Monte-Carlo methods
  • Development of specialised PE/OR reports by experienced medical writers
  • Quality of life studies

Software Tools:

  • SAS® 9.1
  • TreeAge Pro®
  • Query Advisor® (sample size calculations)
  • PROC StatXact® 6.2
  • SigmaPlot®
Contact
Request for Information